Presentation is loading. Please wait.

Presentation is loading. Please wait.

Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria.

Published byEunice Barrett Modified over 6 years ago

Similar presentations

Presentation on theme: "Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria."— Presentation transcript:

1 Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria Panebianco, Maria C. Valerio, Alessandro Giuliani, Martina Pecoraro, Isabella Ceravolo, Giovanni Barchetti, Carlo Catalano, Anwar R. Padhani  European Urology Oncology  Volume 1, Issue 3, Pages (August 2018) DOI: /j.euo Copyright © 2018 European Association of Urology Terms and Conditions

2 Fig. 1 Patient flows and cost associated with diagnosis and therapy in the transrectal ultrasound-guided systematic biopsy (TRUS-Bx) pathway. pts=patients; PCa=prostate cancer; mpMRI=multiparametric magnetic resonance imaging; TRUS-SB=TRUS-guided saturation biopsy; TRUS-TB=TRUS-guided targeted biopsy; csPCa=clinically significant PCa; ciPCa=clinically insignificant PCa; RP=radical prostatectomy; RT=radiotherapy; FT=focal therapy; AS=active surveillance. * If all RT was image-guided radiation therapy. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions

3 Fig. 2 Patient flows and costs associated with diagnosis and therapy in the multiparametric magnetic resonance imaging–guided targeted biopsy (mpMRI-Bx) pathway. pts=patients; TRUS-Bx=transrectal ultrasound-guided systematic biopsy; PCa=prostate cancer; TRUS-SB=TRUS-guided saturation biopsy; TRUS-TBx= TRUS-guided targeted biopsy; csPCa=clinically significant PCa; ciPCa=clinically insignificant PCa; RP=radical prostatectomy; RT=radiotherapy; FT=focal therapy; AS=active surveillance. * If all RT was image-guided radiation therapy. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions

4 Fig. 3 Survival functions for the TRUS/Bx and the mp-MRI/Bx strategies depicting time to reach definitive diagnosis. European Urology Oncology 2018 1, DOI: ( /j.euo ) Copyright © 2018 European Association of Urology Terms and Conditions

5 European Urology Oncology 2018 1, 208-214DOI: (10. 1016/j. euo. 2018
Copyright © 2018 European Association of Urology Terms and Conditions

6 European Urology Oncology 2018 1, 208-214DOI: (10. 1016/j. euo. 2018
Copyright © 2018 European Association of Urology Terms and Conditions

Download ppt "Clinical Utility of Multiparametric Magnetic Resonance Imaging as the First-line Tool for Men with High Clinical Suspicion of Prostate Cancer  Valeria."

Similar presentations

MRI-Ultrasound Fusion-Guided Biopsy of the Prostate: Results of Initial Experience in a Radiation Oncology Department Department of Radiation Oncology.

MRI-Ultrasound Fusion-Guided Biopsy of the Prostate: Results of Initial Experience in a Radiation Oncology Department Department of Radiation Oncology.
V. Scattoni mpMRI of the prostate: Does it change indications for biopsy and repeat biopsy?

V. Scattoni mpMRI of the prostate: Does it change indications for biopsy and repeat biopsy?
The future perspectives in transrectal prostate ultrasound guided biopsy Sung Il Hwang, Hak Jong Lee Prostate International Volume 2, Issue 4, Pages 153-160.

The future perspectives in transrectal prostate ultrasound guided biopsy Sung Il Hwang, Hak Jong Lee Prostate International Volume 2, Issue 4, Pages
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.

Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with.
The PSA Era is not Over for Prostate Cancer

The PSA Era is not Over for Prostate Cancer
Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.

Results of Targeted Biopsy in Men with Magnetic Resonance Imaging Lesions Classified Equivocal, Likely or Highly Likely to Be Clinically Significant Prostate.
Volume 71, Issue 6, Pages (June 2017)

Volume 71, Issue 6, Pages (June 2017)
Volume 69, Issue 3, Pages (March 2016)

Volume 69, Issue 3, Pages (March 2016)
Volume 72, Issue 2, Pages (August 2017)

Volume 72, Issue 2, Pages (August 2017)
Contemporary Clinical Trials

Contemporary Clinical Trials
Volume 4, Issue 5, Pages (September 2017)

Volume 4, Issue 5, Pages (September 2017)
Volume 56, Issue 6, Pages (December 2009)

Volume 56, Issue 6, Pages (December 2009)
Prostate Cancer: Highlights from 2006

Prostate Cancer: Highlights from 2006
Volume 63, Issue 1, Pages (January 2013)

Volume 63, Issue 1, Pages (January 2013)
Volume 53, Issue 5, Pages (May 2008)

Volume 53, Issue 5, Pages (May 2008)
European Urology Oncology

European Urology Oncology
Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?

Who Benefits from Neoadjuvant or Adjuvant Hormone Therapy?
Volume 65, Issue 6, Pages (June 2014)

Volume 65, Issue 6, Pages (June 2014)
Volume 66, Issue 1, Pages (July 2014)

Volume 66, Issue 1, Pages (July 2014)
Volume 69, Issue 3, Pages (March 2016)

Volume 69, Issue 3, Pages (March 2016)

Similar presentations

Ads by Google